Use of Different Blood Pressure Thresholds to Reduce the Number of Home Blood Pressure Monitoring Days Needed for Detecting Hypertension.
blood pressure
blood pressure monitors
cardiovascular diseases
hypertension
Journal
Hypertension (Dallas, Tex. : 1979)
ISSN: 1524-4563
Titre abrégé: Hypertension
Pays: United States
ID NLM: 7906255
Informations de publication
Date de publication:
10 2023
10 2023
Historique:
pmc-release:
01
10
2024
medline:
22
9
2023
pubmed:
14
8
2023
entrez:
14
8
2023
Statut:
ppublish
Résumé
Home blood pressure (BP) monitoring over a 7-day period is recommended to confirm the diagnosis of hypertension. We determined upper and lower home BP thresholds with >90% positive predictive value and >90% negative predictive value using 1 to 6 days of monitoring to identify high home BP (systolic BP ≥130 mm Hg or diastolic BP ≥80 mm Hg) based on 7 days of home BP monitoring. The sample included 361 adults from the Improving the Detection of Hypertension Study who were not taking antihypertensive medication. We used two 7-day periods, at least 3 days apart, the first being a sampling period and the second a reference period. For each number of days in the sampling period, we determined the percentage of participants who had a high likelihood of having (>90% positive predictive value) or not having (>90% negative predictive value) high BP and would not need to continue home BP monitoring. Only the participants in an uncertain category (ie, positive predictive value ≤90% and negative predictive value ≤90%) after each day were carried forward to the next day of home BP monitoring. Of the 361 participants (mean [SD] age of 41.3 [13.2] years; 60.4% women), 38.0% had high home BP during the reference period. There were 63.7%, 17.1%, 10.5%, 3.3%, 3.6%, and 1.4% participants who would not need to continue after 1, 2, 3, 4, 5, and 6 days of monitoring. In most people, high home BP can be identified or excluded with a high degree of confidence with 3 days or less of monitoring.
Sections du résumé
BACKGROUND
Home blood pressure (BP) monitoring over a 7-day period is recommended to confirm the diagnosis of hypertension.
METHODS
We determined upper and lower home BP thresholds with >90% positive predictive value and >90% negative predictive value using 1 to 6 days of monitoring to identify high home BP (systolic BP ≥130 mm Hg or diastolic BP ≥80 mm Hg) based on 7 days of home BP monitoring. The sample included 361 adults from the Improving the Detection of Hypertension Study who were not taking antihypertensive medication. We used two 7-day periods, at least 3 days apart, the first being a sampling period and the second a reference period. For each number of days in the sampling period, we determined the percentage of participants who had a high likelihood of having (>90% positive predictive value) or not having (>90% negative predictive value) high BP and would not need to continue home BP monitoring. Only the participants in an uncertain category (ie, positive predictive value ≤90% and negative predictive value ≤90%) after each day were carried forward to the next day of home BP monitoring.
RESULTS
Of the 361 participants (mean [SD] age of 41.3 [13.2] years; 60.4% women), 38.0% had high home BP during the reference period. There were 63.7%, 17.1%, 10.5%, 3.3%, 3.6%, and 1.4% participants who would not need to continue after 1, 2, 3, 4, 5, and 6 days of monitoring.
CONCLUSIONS
In most people, high home BP can be identified or excluded with a high degree of confidence with 3 days or less of monitoring.
Identifiants
pubmed: 37577827
doi: 10.1161/HYPERTENSIONAHA.123.21118
pmc: PMC10530450
mid: NIHMS1922030
doi:
Substances chimiques
Antihypertensive Agents
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
2169-2177Subventions
Organisme : NHLBI NIH HHS
ID : P01 HL047540
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL007854
Pays : United States
Références
J Hypertens. 2022 Jul 1;40(7):1380-1387
pubmed: 35762478
J Am Soc Hypertens. 2016 Mar;10(3):224-234.e17
pubmed: 26822864
J Am Heart Assoc. 2018 Oct 16;7(20):e008658
pubmed: 30371272
Ann Intern Med. 2015 Nov 3;163(9):691-700
pubmed: 26457954
J Hum Hypertens. 2010 Dec;24(12):779-85
pubmed: 20520631
Am J Hypertens. 2015 May;28(5):595-603
pubmed: 25399016
Am J Hypertens. 2020 Nov 3;33(11):1021-1029
pubmed: 32701144
J Hum Hypertens. 2010 Mar;24(3):158-64
pubmed: 19587701
BMC Med Res Methodol. 2011 Apr 27;11:59
pubmed: 21524301
J Hypertens. 1998 Jun;16(6):725-31
pubmed: 9663911
J Am Coll Cardiol. 2020 Dec 22;76(25):2911-2922
pubmed: 33334418
Circulation. 2020 Jul 28;142(4):e42-e63
pubmed: 32567342
J Hypertens. 2022 Apr 1;40(4):811-818
pubmed: 35102084
J Am Coll Cardiol. 2005 Sep 6;46(5):743-51
pubmed: 16139119
Eur J Public Health. 2014 Oct;24(5):776-81
pubmed: 24088704
J Am Soc Hypertens. 2017 Sep;11(9):573-580
pubmed: 28734798
Eur Heart J. 2018 Sep 1;39(33):3021-3104
pubmed: 30165516
Hypertension. 2019 May;73(5):e35-e66
pubmed: 30827125
BMC Public Health. 2020 Nov 23;20(1):1770
pubmed: 33228626
J Hypertens. 2009 Sep;27(9):1775-83
pubmed: 19491703
Hypertension. 2018 Jun;71(6):1269-1324
pubmed: 29133354
Vasc Health Risk Manag. 2014 Jan 16;10:33-44
pubmed: 24476688
Blood Press Monit. 2008 Feb;13(1):49-54
pubmed: 18199924
J Clin Hypertens (Greenwich). 2016 Nov;18(11):1086-1094
pubmed: 27126770
Am J Hypertens. 2019 Mar 16;32(4):350-364
pubmed: 30668627
Can J Cardiol. 2016 May;32(5):569-88
pubmed: 27118291